Vanguard Group Inc Ironwood Pharmaceuticals Inc Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 22,038,097 shares of IRWD stock, worth $98.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,038,097

Previous 21,563,414 2.2%

Holding current value

$98.1 Million

Previous $141 Million 35.58%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.93 - $7.04 $1.87 Million - $3.34 Million	474,683 Added 2.2%	22,038,097 $90.6 Million
Q2 2024 Aug 13, 2024	BUY	$5.58 - $8.61 $11.4 Million - $17.6 Million	2,042,048 Added 10.46%	21,563,414 $141 Million
Q1 2024 May 10, 2024	BUY	$8.32 - $15.45 $29 Million - $53.9 Million	3,487,821 Added 21.75%	19,521,366 $170 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $10 Million - $13.1 Million	1,137,845 Added 7.64%	16,033,545 $183 Million
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $405,570 - $557,966	49,160 Added 0.33%	14,895,700 $143 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $1.29 Million - $1.48 Million	-127,776 Reduced 0.85%	14,846,540 $158 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $2.51 Million - $3.04 Million	241,747 Added 1.64%	14,974,316 $158 Million
Q4 2022 Feb 10, 2023	BUY	$9.9 - $12.43 $2.46 Million - $3.08 Million	248,012 Added 1.71%	14,732,569 $183 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $47,992 - $58,594	4,733 Added 0.03%	14,484,557 $150 Million
Q2 2022 Aug 12, 2022	BUY	$11.05 - $12.72 $12.4 Million - $14.3 Million	1,123,496 Added 8.41%	14,479,824 $167 Million
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $1.39 Million - $1.69 Million	-131,434 Reduced 0.97%	13,356,328 $168 Million
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $343,490 - $441,224	31,629 Added 0.24%	13,487,762 $157 Million
Q3 2021 Nov 12, 2021	SELL	$11.92 - $13.92 $5.26 Million - $6.14 Million	-441,046 Reduced 3.17%	13,456,133 $176 Million
Q2 2021 Aug 13, 2021	BUY	$10.16 - $13.11 $141 Million - $182 Million	13,897,179 New	13,897,179 $179 Million

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Ironwood Pharmaceuticals Inc Transaction History